Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Research Report: Domainex Ltd. - Product Pipeline Review - 2013


Print article Print article
2014-01-27 08:32:47 - Fast Market Research recommends "Domainex Ltd. - Product Pipeline Review - 2013" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Domainex Ltd. - Product Pipeline Review - 2013" provides data on the Domainex Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Domainex Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Domainex Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Domainex Ltd. - Brief Domainex Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Domainex Ltd. human therapeutic division.
* Overview of

pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Domainex Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Domainex Ltd.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769309_domainex_ltd_product_pipeline_review_ ..

Reasons to Get this Report

* Evaluate Domainex Ltd.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Domainex Ltd. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Domainex Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Domainex Ltd..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Domainex Ltd. and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Domainex Ltd. Snapshot
Domainex Ltd. Overview
Key Information
Key Facts
Domainex Ltd. - Research and Development Overview
Key Therapeutic Areas
Domainex Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Domainex Ltd. - Pipeline Products Glance
Domainex Ltd. - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Domainex Ltd. - Drug Profiles
Drug Targeting KMT-1
Product Description
Mechanism of Action
R&D Progress
Drug Targeting KMT-2
Product Description
Mechanism of Action
R&D Progress
Drug Targeting KMT-3
Product Description
Mechanism of Action
R&D Progress
Drug Targeting KMT-4
Product Description
Mechanism of Action
R&D Progress
Drug Targeting KMT-5
Product Description
Mechanism of Action
R&D Progress
TBK1/ IKKe Inhibitors
Product Description
Mechanism of Action
R&D Progress
Domainex Ltd. - Pipeline Analysis
Domainex Ltd. - Pipeline Products by Therapeutic Class
Domainex Ltd. - Pipeline Products by Target
Domainex Ltd. - Pipeline Products by Molecule Type
Domainex Ltd. - Pipeline Products by Mechanism of Action
Domainex Ltd. - Recent Pipeline Updates
Domainex Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Domainex Ltd., Key Information
Domainex Ltd., Key Facts
Domainex Ltd. - Pipeline by Indication, 2013
Domainex Ltd. - Pipeline by Stage of Development, 2013
Domainex Ltd. - Monotherapy Products in Pipeline, 2013
Domainex Ltd. - Discovery, 2013
Domainex Ltd. - Pipeline by Therapeutic Class, 2013
Domainex Ltd. - Pipeline by Target, 2013
Domainex Ltd. - Pipeline by Molecule Type, 2013
Domainex Ltd. - Pipeline Products by Mechanism of Action, 2013
Domainex Ltd. - Recent Pipeline Updates, 2013

List of Figures
Domainex Ltd. - Pipeline by Top 10 Indication, 2013
Domainex Ltd. - Pipeline by Top 10 Therapeutic Class, 2013
Domainex Ltd. - Pipeline by Top 10 Target, 2013
Domainex Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com